Molecular Targeted α-Particle Therapy for Oncologic Applications
نویسندگان
چکیده
منابع مشابه
Molecular pathways: targeted α-particle radiation therapy.
An α-particle, a (4)He nucleus, is exquisitely cytotoxic and indifferent to many limitations associated with conventional chemo- and radiotherapy. The exquisite cytotoxicity of α-radiation, the result of its high mean energy deposition [high linear energy transfer (LET)] and limited range in tissue, provides for a highly controlled therapeutic modality that can be targeted to selected malignant...
متن کاملMolecular Pathways Molecular Pathways: Targeted a-Particle Radiation Therapy
An a-particle, a He nucleus, is exquisitely cytotoxic and indifferent to many limitations associated with conventional chemoand radiotherapy. The exquisite cytotoxicity ofa-radiation, the result of its highmean energy deposition [high linear energy transfer (LET)] and limited range in tissue, provides for a highly controlled therapeutic modality that can be targeted to selected malignant cells ...
متن کاملCombining targeted therapy with immunotherapy (interferon-α)
Imatinib revolutionized gastrointestinal stromal tumor (GIST) treatment but median-progression-free-survival of unresectable/metastatic disease is < 2 y. B-RAF(V600)-mutated-melanoma responds to vemurafenib dramatically but median-progression-free-survival is < 9 mo. Combining imatinib with immunotherapy (peginterferon α-2b) in GIST showed significant induction of antitumor immunity and highly ...
متن کاملApatinib for molecular targeted therapy in tumor
As tumor angiogenesis is one of the hallmarks of cancer, the inhibition of vascular endothelial growth factor signaling has become an attractive anticancer approach. Apatinib, a small-molecule inhibitor of vascular endothelial growth factor receptor-2, has demonstrated encouraging anticancer activity across a broad range of malignancies, including gastric cancer, non-small-cell lung cancer, bre...
متن کاملMolecular targeted therapy for advanced gastric cancer
Although medical treatment has been shown to improve quality of life and prolong survival, no significant progress has been made in the treatment of advanced gastric cancer (AGC) within the last two decades. Thus, the optimum standard first-line chemotherapy regimen for AGC remains debatable, and most responses to chemotherapy are partial and of short duration; the median survival is approximat...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: American Journal of Roentgenology
سال: 2014
ISSN: 0361-803X,1546-3141
DOI: 10.2214/ajr.14.12554